Is 7-OH Legal in Idaho? The Pending 2026 Federal Ban, Explained

Short version: as of September 2, 2026, 7-OH is still legal in Idaho. The state hasn’t restricted it, and the federal ban on concentrated 7-OH still hasn’t taken effect. For now, it’s legal to buy and sell.

The “yet” is still doing real work. The DEA filed back in July to put concentrated 7-OH in Schedule I, and that order can still publish, though it’s further out than it looked in August: the comment period on the threshold that defines the ban was extended to September 10, 2026. When the order does land, it changes the answer for the concentrated, isolated products, the tablets and shots, not for natural leaf kratom, which stays legal in Idaho either way. Those two get lumped under one name, and that mix-up is the whole reason people are searching whether Idaho is banning kratom.

What 7-OH is, and how it differs from kratom

7-hydroxymitragynine, shortened to 7-OH, is one of the alkaloids in the kratom plant, Mitragyna speciosa. In raw leaf it’s a minor one. The DEA’s own filing puts it at under two percent of the total alkaloid content, often just a trace. Mitragynine is the major alkaloid in the plant; 7-OH is the small one riding along with it.

The product that set off the 2026 crackdown isn’t the leaf. It’s isolated 7-OH, concentrated far past what the plant makes and pressed into tablets, gummies, shots, and dissolvable strips. Same molecule, very different amount. That gap is the entire story, because the law is being written around a concentration line, not around the plant.

Is 7-OH legal in Idaho right now?

Yes, and it isn’t close at the state level. Idaho’s controlled substances schedules, in Idaho Code 37-2705, don’t list kratom, mitragynine, or 7-hydroxymitragynine. If a substance isn’t on the schedule, it isn’t controlled in Idaho, and none of these are. The state took two runs at changing kratom law in 2026, one bill to ban it and one to regulate it, and both failed, which our companion guide on kratom’s Idaho status walks through. So Idaho itself has not banned 7-OH or set a purchase age for it.

All the pressure on 7-OH is federal, and as of this writing that federal ban hasn’t taken effect. So the straight answer today is that 7-OH is legal to buy and sell in Idaho. The one real caveat is timing: the concentrated form is still on a federal clock, and the next two sections lay out where that clock actually stands after August 26.

What the DEA actually did in 2026

On July 6, 2026, the DEA published a notice of intent to place 7-OH above a set threshold into Schedule I of the Controlled Substances Act, the most restrictive tier under federal drug law. A notice of intent is the required first step, not the ban itself. The filing says the temporary order “will be published in the Federal Register on or after August 5, 2026,” and it takes effect the day that order publishes.

As of September 2, 2026, that order still hadn’t published. The notice of intent was on the books; the scheduling order was not. If anything the timeline slipped: on August 26, 2026 the Department of Health and Human Services extended the public comment period on the proposed 7-OH threshold to September 10, 2026, so the input that feeds the decision is still open. When the order does land, it places 7-OH in Schedule I for two years, with a possible one-year extension.

One line in the filing is the one to hold onto: the DEA drew the ban around concentrated 7-OH, and it does not reach natural leaf below the threshold.

What changed on August 26, 2026

One piece of the 7-OH story did move on August 26, and it’s easy to misread. The DEA issued a temporary order placing three substances the agency calls “7-hydroxymitragynine-related” into Schedule I: mitragynine pseudoindoxyl, MGM-15, and MGM-16, along with their isomers, esters, ethers, and salts. It’s effective August 26, 2026 through August 26, 2028, on a finding that scheduling them was necessary to avoid an imminent hazard to public safety.

Read the names carefully, because this is the part that gets reported as “the 7-OH ban.” It isn’t. Those three are relatives of 7-OH, not 7-OH itself, and not leaf kratom. The 7-OH scheduling order, the one built around the concentration threshold, is the piece that’s still pending. So if you’re tracking what’s legal to buy: the August 26 order controls products built on mitragynine pseudoindoxyl, MGM-15, or MGM-16, while concentrated 7-OH above the threshold is still legal at the federal level until the separate 7-OH order publishes.

The threshold, in plain terms

The 7-OH ban is a concentration line, not a blanket. The July filing schedules 7-OH when a product runs over the threshold: more than 0.050 percent 7-OH by dry weight for plant material, or, for anything synthesized or processed into extracts, concentrates, edibles, or pressed pills, more than 0.050 percent by weight or more than 1.00 milligram of 7-OH in the article.

Hold that against the shelf. A concentrated 7-OH tablet or shot is built to clear that line, because clearing it is the point of the product. Ordinary leaf kratom, where 7-OH sits under two percent of the alkaloids and usually much lower, falls under it. The threshold is exactly what separates the two, and it’s the number the extended comment period is still fighting over.

Where the FDA fits

The FDA got there first. In July 2025 it recommended that the DEA schedule concentrated 7-OH, and it was explicit that it was “specifically targeting 7-OH, a concentrated byproduct of the kratom plant,” not natural kratom leaf. The agency classifies 7-OH as an opioid, had already sent warning letters to seven companies selling 7-OH tablets, gummies, and shots, and has since seized products and stated the products aren’t approved for any use and can’t lawfully go in dietary supplements or foods.

That’s the federal government’s stated basis for the action, not a claim we’re making about anyone’s health. It’s also why the concentrated corner of this market is the risky place to be standing.

What this means if you buy kratom in Cache Valley

If you buy plain leaf kratom, the ground under you hasn’t shifted. Leaf kratom is legal in Idaho, it isn’t part of any of the 2026 federal action, and it stays on the shelf. We carry leaf-based kratom, and we still stock 7-OH too, because it is legal to sell in Idaho today. The August 26 order didn’t touch it; that order controlled three related substances, not 7-OH itself. We keep 7-OH on the shelf right up until its own federal ban takes effect; the day that Schedule I order publishes, the concentrated 7-OH products come off and the leaf stays.

Coming from the Utah side, the rules on kratom are tighter to begin with, pure leaf only and buyers 21 and older, which the Idaho and Utah kratom guide covers. Either way, for kratom in Logan or anywhere else in the valley, here is the honest read: leaf kratom is the settled, long-term option, while concentrated 7-OH is legal to buy here in Idaho for now but still on a federal clock, one whose timeline slipped when the comment period was pushed to September 10, so it is the piece that goes away when the 7-OH order lands. We stock both today and card every kratom customer at 21 and older, the same as pouches and vapes.

Sources and methodology

Every legal claim here was verified against a primary source on September 2, 2026. Federal Register and FDA pages block automated fetching, so each was read from the Federal Register’s own JSON API and, where needed, rendered in a browser and quoted from the rendered text.

• DEA 7-OH action: the notice of intent to place 7-hydroxymitragynine above a specified threshold in Schedule I, published at 91 FR 40917 on July 6, 2026, including the threshold definition and the “on or after August 5, 2026” publication language. A Federal Register API check on September 2, 2026 found no 7-OH scheduling order published after that notice; the two newest 7-OH documents were both dated August 26, so the 7-OH order was still pending on that date.
• August 26 comment extension: HHS notice Hydroxymitragynine Above a Specified Threshold in Schedule I; Extension of Comment Period (document 2026-17409, published August 26, 2026), extending the comment period on the proposed 7-OH threshold to September 10, 2026, with comments provided to the Secretary of Health and Human Services for consideration by the Attorney General.
• August 26 three-substance order: DEA temporary order Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (document 2026-17429, published August 26, 2026), placing those three 7-OH-related substances in Schedule I effective August 26, 2026 through August 26, 2028, on an imminent-hazard finding. It does not cover 7-OH itself or natural leaf kratom.
• Natural leaf: the July DEA filing describes 7-OH as under two percent of the total alkaloid content in natural leaf, and the DEA announcement states the action does not apply to botanical kratom below the threshold.
• FDA: the July 2025 recommendation to schedule concentrated 7-OH, and the FDA’s 7-OH resource page.
• Idaho: Idaho Code 37-2705, where kratom and its alkaloids are absent from the schedules. Idaho’s 2026 bills and Utah’s rules are carried from our companion guide, Is Kratom Legal in Idaho?

The 7-OH order is still expected but no longer imminent after the comment extension, so if you’re making a decision that turns on 7-OH’s status, check the current Federal Register listing or confirm with the retailer.